JDMAX
Price
$140.39
Change
-$0.72 (-0.51%)
Updated
Oct 7 closing price
Net Assets
23.75B
LGOQX
Price
$27.58
Change
-$0.09 (-0.33%)
Updated
Oct 7 closing price
Net Assets
717.5M
Interact to see
Advertisement

JDMAX vs LGOQX

Header iconJDMAX vs LGOQX Comparison
Open Charts JDMAX vs LGOQXBanner chart's image
Janus Henderson Enterprise A
Price$140.39
Change-$0.72 (-0.51%)
VolumeN/A
Net Assets23.75B
Lord Abbett Growth Opportunities R2
Price$27.58
Change-$0.09 (-0.33%)
VolumeN/A
Net Assets717.5M
JDMAX vs LGOQX Comparison Chart in %
View a ticker or compare two or three
VS
JDMAX vs. LGOQX commentary
Oct 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JDMAX is a Buy and LGOQX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
JDMAX has more cash in the bank: 23.7B vs. LGOQX (717M). JDMAX pays higher dividends than LGOQX: JDMAX (0.75) vs LGOQX (0.00). JDMAX was incepted earlier than LGOQX: JDMAX (16 years) vs LGOQX (18 years). LGOQX (1.50) is less costly to investors than JDMAX (1.14). LGOQX is a more actively managed with annual turnover of: 117.00 vs. JDMAX (15.00). LGOQX has a lower initial minimum investment than JDMAX: LGOQX (0) vs JDMAX (2500). LGOQX annual gain was more profitable for investors over the last year : 32.84 vs. JDMAX (0.93). LGOQX return over 5 years is better than : -0.29 vs. JDMAX (-1.60).
JDMAXLGOQXJDMAX / LGOQX
Total Expense Ratio1.141.3187%
Annual Report Gross Expense Ratio1.141.5076%
Fund Existence16 years18 years-
Gain YTD5.62121.30626%
Front Load6%N/A-
Min. Initial Investment25000-
Min. Initial Investment IRAN/AN/A-
Net Assets23.7B717M3,305%
Annual Yield % from dividends0.750.00-
Returns for 1 year0.9332.843%
Returns for 3 years18.5272.4026%
Returns for 5 years-1.60-0.29554%
Returns for 10 years63.9235.17182%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AARD17.410.36
+2.11%
Aardvark Therapeutics Inc
CASH74.520.52
+0.70%
Pathward Financial
RAAQU10.330.03
+0.29%
Real Asset Acquisition Corp.
FRT97.60-1.14
-1.15%
Federal Realty Investment Trust
SKYE1.66-0.24
-12.63%
Skye Bioscience